NextCure, Inc. - Common Stock (NXTC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2019 to Q3 2025

Type / Class
Equity / Common Stock
Symbol
NXTC on Nasdaq
Shares outstanding
28,027,744
Price per share
$5.86
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
21,833
Total reported value
$127,941
% of total 13F portfolios
0%
Share change
-10,523,357
Value change
-$6,933,790
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NextCure, Inc. - Common Stock (NXTC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CITIGROUP INC 4.3% $578,854 1,205,193 Citigroup Global Markets Inc. 31 Mar 2025

As of 30 Sep 2025, 1 institutional investors reported holding 21,833 shares of NextCure, Inc. - Common Stock (NXTC). This represents 0.08% of the company’s total 28,027,744 outstanding shares.

Institutional Holders of NextCure, Inc. - Common Stock (NXTC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 21,833 $127,941 -$6,933,790 $5.86 1
2025 Q2 10,545,575 $5,647,089 -$10,911,407 $0.46 29
2025 Q1 15,365,612 $7,377,835 -$659,368 $0.48 38
2024 Q4 14,576,884 $11,238,883 -$3,082,628 $0.77 45
2024 Q3 15,865,008 $21,732,882 -$163,706 $1.37 44
2024 Q2 16,009,076 $25,452,390 -$417,829 $1.59 47
2024 Q1 16,144,047 $35,999,098 +$5,582,509 $2.23 47
2023 Q4 13,341,936 $15,275,154 -$369,898 $1.14 42
2023 Q3 12,895,574 $16,633,500 -$700,865 $1.29 39
2023 Q2 13,318,175 $23,970,765 +$169,800 $1.80 41
2023 Q1 13,146,934 $19,455,952 -$289,710 $1.48 41
2022 Q4 13,389,483 $18,876,066 -$4,994,364 $1.41 43
2022 Q3 15,200,411 $41,642,784 +$1,693,500 $2.75 46
2022 Q2 14,410,971 $67,723,572 +$5,753,511 $4.70 47
2022 Q1 12,763,610 $62,039,105 -$6,638,121 $4.86 53
2021 Q4 14,143,892 $84,863,310 -$3,942,944 $6.00 66
2021 Q3 14,744,510 $99,462,595 -$2,563,119 $6.74 67
2021 Q2 14,846,623 $119,218,911 -$19,373,106 $8.03 73
2021 Q1 17,110,184 $171,279,328 +$32,792,051 $10.01 88
2020 Q4 13,797,509 $150,393,717 -$35,610,448 $10.90 77
2020 Q3 17,562,802 $154,514,375 -$77,102,898 $8.80 69
2020 Q2 20,182,186 $432,709,887 -$5,057,626 $21.44 84
2020 Q1 20,199,628 $748,795,307 -$2,020,341 $37.07 79
2019 Q4 20,192,693 $1,137,414,222 +$380,880,844 $56.33 86
2019 Q3 11,286,695 $348,192,350 +$51,109,915 $30.85 50
2019 Q2 10,754,678 $161,093,210 +$161,092,835 $14.98 42